Sponsor Pipeline

Astellas Gene Therapies Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
2
Recruiting
1
Phase 3
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-19 NCT06581146
A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition
date change Primary completion pushed: 2027-05-31 -> 2027-12-31
2026-07-19 NCT06581146
A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition
date change Completion pushed: 2027-05-31 -> 2027-12-31
Active Trials by Phase
Phase 2/3
1
Phase 1/2
2
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT03199469 A Study of AT132 in Young Children With X-Linked Myotubular Myopathy (XLMTM) X-Linked Myotubular Myopathy Active, Not Recruiting
Phase 1/2
NCT07052929 Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need… X-Linked Myotubular Myopathy Recruiting
NCT04174105 Gene Transfer Study in Patients With Late Onset Pompe Disease Pompe Disease (Late-onset) Active, Not Recruiting
Not specified
NCT06581146 A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition X-Linked Myotubular Myopathy Recruiting
NCT06150820 A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe… Pompe Disease (Late-onset) Active, Not Recruiting
Get alerts when Astellas Gene Therapies's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free